Paratek is a biopharmaceutical company that researches, develops, and commercializes antibiotic therapies for the treatment of infectious diseases.Read more
Paratek's revenue is the ranked lowest among it's top 10 competitors. The top 10 competitors average 1.9B. Over the last four quarters, Paratek's revenue has grown by 320.9%. Specifically, in Q2 2021's revenue was $57.5M; in Q1 2021, it was $16.4M; in Q4 2020, it was $16M; in Q3 2020, Paratek's revenue was $13.7M.